FDA guidance encourages remote patient monitoring during pandemic

In response to the COVID-19 outbreak, FDA released guidance Friday encouraging companies and healthcare professionals to expand the use of remote monitoring technology to "help eliminate unnecessary patient contact and ease the burden on hospitals, other health care facilities, and health care professionals."

The agency's recommendations apply to non-invasive monitoring devices, such as thermometers, electrocardiographs, stethoscopes, pulse oximeters and cardiac monitors, and those that measure blood pressure and respiratory rate...